Your browser doesn't support javascript.
loading
Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men.
García-González, Pablo; de Rojas, Itziar; Moreno-Grau, Sonia; Montrreal, Laura; Puerta, Raquel; Alarcón-Martín, Emilio; Quintela, Inés; Orellana, Adela; Andrade, Victor; Adami, Pamela V Martino; Heilmann-Heimbach, Stefanie; Gomez-Garre, Pilar; Periñán, María Teresa; Alvarez, Ignacio; Diez-Fairen, Monica; Nuñez Llaves, Raul; Olivé Roig, Claudia; Garcia-Ribas, Guillermo; Menéndez-González, Manuel; Martínez, Carmen; Aguilar, Miquel; Buongiorno, Mariateresa; Franco-Macías, Emilio; Saez, Maria Eugenia; Cano, Amanda; Bullido, Maria J; Real, Luis Miguel; Rodríguez-Rodríguez, Eloy; Royo, Jose Luís; Álvarez, Victoria; Pastor, Pau; Piñol-Ripoll, Gerard; Mir, Pablo; Lara, Miguel Calero; Padilla, Miguel Medina; Sánchez-Juan, Pascual; Carracedo, Angel; Valero, Sergi; Hernandez, Isabel; Tàrraga, Lluis; Ramirez, Alfredo; Boada, Mercé; Ruiz, Agustín.
Afiliação
  • García-González P; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • de Rojas I; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Moreno-Grau S; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Montrreal L; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Puerta R; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Alarcón-Martín E; Galatea Bio Inc., Hialeah, FL 33010, USA.
  • Quintela I; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Orellana A; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Andrade V; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Adami PVM; Grupo de Medicina Xenómica, Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII), Universidade de Santiago de Compostela, 15705 Santiago de Compostela, Spain.
  • Heilmann-Heimbach S; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Gomez-Garre P; Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Cologne, 50937 Cologne, Germany.
  • Periñán MT; Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Clinic Bonn, 53127 Bonn, Germany.
  • Alvarez I; Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Cologne, 50937 Cologne, Germany.
  • Diez-Fairen M; Institute of Human Genetics, School of Medicine & University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.
  • Nuñez Llaves R; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Olivé Roig C; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
  • Garcia-Ribas G; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Menéndez-González M; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
  • Martínez C; Fundació Docència i Recerca MútuaTerrassa, 08221 Terrassa, Spain.
  • Aguilar M; Memory Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, 08221 Terrassa, Spain.
  • Buongiorno M; Fundació Docència i Recerca MútuaTerrassa, 08221 Terrassa, Spain.
  • Franco-Macías E; Memory Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, 08221 Terrassa, Spain.
  • Saez ME; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Cano A; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Bullido MJ; Hospital Universitario Ramon y Cajal, IRYCIS, 28034 Madrid, Spain.
  • Real LM; Servicio de Neurología, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
  • Rodríguez-Rodríguez E; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Asturias, Spain.
  • Royo JL; Departamento de Medicina, Universidad de Oviedo, 33011 Oviedo, Spain.
  • Álvarez V; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Asturias, Spain.
  • Pastor P; Servicio de Neurología, Hospital Universitario de Cabueñes, 33394 Gijón, Spain.
  • Piñol-Ripoll G; Fundació Docència i Recerca MútuaTerrassa, 08221 Terrassa, Spain.
  • Mir P; Memory Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, 08221 Terrassa, Spain.
  • Lara MC; Fundació Docència i Recerca MútuaTerrassa, 08221 Terrassa, Spain.
  • Padilla MM; Memory Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, 08221 Terrassa, Spain.
  • Sánchez-Juan P; Unidad de Demencias, Servicio de Neurología y Neurofisiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla, 41013 Sevilla, Spain.
  • Carracedo A; CAEBI, Centro Andaluz de Estudios Bioinformáticos, 41013 Sevilla, Spain.
  • Valero S; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Hernandez I; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Tàrraga L; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Ramirez A; Centro de Biología Molecular Severo Ochoa (UAM-CSIC), 28049 Madrid, Spain.
  • Boada M; Instituto de Investigacion Sanitaria 'Hospital la Paz' (IdIPaz), 28029 Madrid, Spain.
  • Ruiz A; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, 41013 Sevilla, Spain.
Int J Mol Sci ; 24(2)2023 Jan 04.
Article em En | MEDLINE | ID: mdl-36674414
ABSTRACT
Mosaic loss of chromosome Y (mLOY) is a common ageing-related somatic event and has been previously associated with Alzheimer's disease (AD). However, mLOY estimation from genotype microarray data only reflects the mLOY degree of subjects at the moment of DNA sampling. Therefore, mLOY phenotype associations with AD can be severely age-confounded in the context of genome-wide association studies. Here, we applied Mendelian randomisation to construct an age-independent mLOY polygenic risk score (mloy-PRS) using 114 autosomal variants. The mloy-PRS instrument was associated with an 80% increase in mLOY risk per standard deviation unit (p = 4.22 × 10-20) and was orthogonal with age. We found that a higher genetic risk for mLOY was associated with faster progression to AD in men with mild cognitive impairment (hazard ratio (HR) = 1.23, p = 0.01). Importantly, mloy-PRS had no effect on AD conversion or risk in the female group, suggesting that these associations are caused by the inherent loss of the Y chromosome. Additionally, the blood mLOY phenotype in men was associated with increased cerebrospinal fluid levels of total tau and phosphorylated tau181 in subjects with mild cognitive impairment and dementia. Our results strongly suggest that mLOY is involved in AD pathogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha